|
|
News Breaks | | | | December 16, 2012 | | 13:55 EDT |  | BIO | Bio-Rad signs definitive agreement to acquire AbD Serotec
Bio-Rad Laboratories announced that it has signed a definitive agreement to acquire AbD Serotec, a division of MorphoSys AG for 53 million euros in cash. The transaction is subject to certain closing conditions and is expected to be completed in January. | |
|
News For BIO From The Last 14 Days Check below for free stories on BIO the last two weeks. |
|
|
| May 7, 2013 | | 16:43 EDT |  | BIO | Bio-Rad reports Q1 EPS 68c, consensus $1.04
Reports Q1 revenue $499.7M, consensus $506.34M. The company said, "We continued to see softness in the research markets, impacting our results in the first quarter. This softness, together with a number of operational factors, affected our profitability. While first-quarter sales growth was slow, our outlook for the remainder of the year is cautiously optimistic." | | | 05:52 EDT |  | BIO | Bio-Rad coverage assumed with a Buy at Jefferies
 Subscribe for More Information | | | May 6, 2013 | | 07:24 EDT |  | BIO | American Association of Immunologists to hold annual meeting
Annual Meeting of the AAI 2013 is being held in Honolulu, Hawaii on May 3-7. | |
|
|
|
|
|
|
